Partner at Samsara BioCapital · Joined 2017
View Live Interactive Profile →Abe Bassan is a Partner at Samsara BioCapital and joined the firm in 2017 when the fund was launched. He was previously Director of Program Biology at Revolution Medicines, where the firm states he co-led the initial stages of the company's 4EBP1/mTORC1 cancer programme. Before that he was at bluebird bio as project manager for the company's beta-Thalassemia, Sickle Cell Anemia and ALD gene therapy programmes, and before bluebird he was an Associate at Third Rock Ventures, where the firm states he was involved in that firm's investment in bluebird bio and in concept creation for Blueprint Medicines. He was also the founder of Aurora Medical, a molecular diagnostics testing services company. He received an A.B. in Molecular Biology from Princeton University and an M.S. in Developmental Biology from Stanford University. No current board seat is stated for him on Samsara's team page.